VIIN Industry Alliance Collaborative Project Grants

$20,000 is available for projects which focus on infectious disease and immunity as it relates to infection.

About

The Victorian Infection and Immunity Network Industry Alliance has a number of grants for Collaborative Projects between Victorian researchers and Victorian-based industry partners.

This is the second round of funding for Collaborative Projects on infectious disease and immunity as it relates to infection.

The Victorian Infection and Immunity Network (VIIN) brings together researchers from diverse disciplines across various nodes within Victoria who have an interest in infection and immunity. Through events such as the Lorne Infection and Immunity Conference and annual postgraduate and postdoctoral research symposia, VIIN connects established and emerging infection and immunity researchers with the goal of seeding new collaborations and strengthening research performance and capabilities.

Objectives

The aim of funding Industry-Driven Collaborative Projects for Innovation in Infection and Immunity is to foster collaborations between businesses and academics which lead to innovative outcomes to questions posed about infectious disease and immunity as it relates to infection.

Eligible Projects

We are interested in receiving applications that have a clearly identified investment event that will add value to the intellectual property position for further commercial development. The investments will be clearly characterised by experiments that deliver proof of concept and enhanced value. Preliminary data and your patent position should be included in the application, as well as a limited number of references.

It is also important to the VIIN Industry Alliance that significant outputs from the proposal can be achieved within 6-9 months from the date of funding, December 2013. Your application must describe the outputs of your Project and provide a realistic assessment of achieving them by June – September 2014.

We envisage that funded Projects have the potential for developing into applications for ARC Linkage or NHMRC Development grants, or to the possibility of being presented to the Medical Research Commercialisation Fund for further investment. In your application, you may wish to tell us about other potential outcomes you foresee for your proposal.

Eligible Applicants

All projects are required to have at least two co-applicants, one from a Victorian-based academic institution and one from a business. The business partner must be either based in Victoria or providing considerable economic benefits to Victoria; in either case, applicants are obliged to provide evidence in the Application Form. If there are more than two applicants, please replicate the tables in Section 1 of the Application Form to provide the necessary information for each applicant.

Applicants are strongly advised to have consulted a business development expert during the preparation of your application. This expert does not need to be from the Business Development Office of your university. This part of preparing your application should not incur you significant costs; please contact the Project Officer if you are having difficulty identifying a suitable expert.

Funding

Each Project will be funded to a maximum value of approximately $20,000, but applicants are not obliged to request this maximum amount.

Timing

Applications for grants for Collaborations in Infection and Immunity close Friday 1 November, 5pm 2013.

Additional Information

Application Guidelines
Application Form

What is the #1 grant for start-ups?

12,000+ companies access the R&D tax incentive per year that yields a CASH REBATE of up to 43.5%.
This might be perfect your start up.
Do you want to know more?

Bulletpoint is a Melbourne-based consultancy specialising in guiding businesses through the complex process of the R&D tax incentive. With a decade of experience under our belt, we’re proud to be led by Australia’s highest-rated R&D tax consultant. We’ve successfully lodged over 500 R&D claims, demonstrating a proven track record.

Our approach is straightforward and personable, focusing on cutting through the jargon to help businesses truly understand the definition of R&D in government terms. We’re passionate about what we do, and our clients appreciate this, often commenting on the difference our expertise has made to their businesses. They’ve praised us for uncovering grants they wouldn’t have otherwise known about and for making the whole process less stressful for them.

We’re proud to have an average rating of 4.8 stars from over 250 Google reviews. Despite our success, we continue to strive for improvement, learning from every piece of feedback we receive.

At Bulletpoint, we excel in helping businesses navigate the complexities of the R&D tax incentive process, ensuring they reap the benefits they deserve. As experts in our field, we’re well-versed in what works and what doesn’t when it comes to aligning businesses’ perceptions of R&D with the government’s eligibility criteria.

So, if you’re looking for accessible expertise and a proven success rate, you’ll find it with us at Bulletpoint. We’re ready to guide you through the R&D tax incentive process with a blend of professionalism and personality, ensuring your experience with us is not just successful, but enjoyable as well.